Coverage with Evidence Development Ethical Issues and Policy Implications
Coverage with evidence development (CED) is an evolving method of providing provisional access to novel medical interventions while generating the evidence needed to determine whether unconditional coverage is warranted. In this article we review the policy rationale for CED and present a normative analysis that addresses ethical concerns and policy implications..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2008 |
|---|---|
| Erschienen: |
2008 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
|---|---|
| Enthalten in: |
Medical Care - 46(2008), 7, Seite 746-751 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Miller, Franklin G. [VerfasserIn] |
|---|
| Links: |
|---|
| BKL: | |
|---|---|
| Themen: |
Clinical research |
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
JST057286817 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | JST057286817 | ||
| 003 | DE-627 | ||
| 005 | 20230505085350.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 150325s2008 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)JST057286817 | ||
| 035 | |a (JST)40221731 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.10 |2 bkl | ||
| 100 | 1 | |a Miller, Franklin G. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Coverage with Evidence Development Ethical Issues and Policy Implications |
| 264 | 1 | |c 2008 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Coverage with evidence development (CED) is an evolving method of providing provisional access to novel medical interventions while generating the evidence needed to determine whether unconditional coverage is warranted. In this article we review the policy rationale for CED and present a normative analysis that addresses ethical concerns and policy implications. | ||
| 540 | |a Copyright 2008 Lippincott Williams & Wilkins | ||
| 650 | 4 | |a health insurance | |
| 650 | 4 | |a coverage | |
| 650 | 4 | |a Medicare | |
| 650 | 4 | |a clinical research | |
| 650 | 4 | |a coercion | |
| 655 | 4 | |a research-article | |
| 700 | 1 | |a Pearson, Steven D. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i in |t Medical Care |d Lippincott Williams & Wilkins, a business of Wolters Kluwer Health, 1963 |g 46(2008), 7, Seite 746-751 |w (DE-627)JST057263272 |x 15371948 |7 nnns |
| 773 | 1 | 8 | |g volume:46 |g year:2008 |g number:7 |g pages:746-751 |
| 856 | 4 | 0 | |u https://www.jstor.org/stable/40221731 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_JST | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.10 |q ASE |
| 951 | |a AR | ||
| 952 | |d 46 |j 2008 |e 7 |h 746-751 | ||